Frederic Kaye
University of Florida
H-index: 57
North America-United States
Top articles of Frederic Kaye
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
PROTAC-mediated dual degradation of BCL-xL and BCL-2 is a highly effective therapeutic strategy in small-cell lung cancer | Cells | Sajid Khan Lin Cao Janet Wiegand Peiyi Zhang Maria Zajac-Kaye | 2024/3/17 |
Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032) | Journal for Immunotherapy of Cancer | Margaret Callahan Asim Amin Frederic J Kaye Michael A Morse Matthew H Taylor | 2024 |
Elucidating the significance of amphiregulin and its implications for EGFR inhibition strategies in LKB1-mutant NSCLC | Cancer Research | Xzaviar Kaymar Solone Xin Zhou Mu Yu Jennifer W Li Finn Rimay | 2024/3/22 |
Discovery of a first-in-class multifunctional TYMS non-classical antifolate inhibitors with potent in vivo activity that prolongs survival | Cancer Research | Peter Elias Dib Maria Guijarro Patrick Kellish Nick Paciaroni Akbar Nawab | 2023/4/4 |
TYMS as a novel target for AAV-based therapy | Cancer Research | Vinod Vijayakurup Benjamin Meyer Akbar Nawab Frederic J Kaye Maria V Guijarro | 2023/4/4 |
PROTAC therapy as a new targeted therapy for lung cancer | Jennifer W Li Guangrong Zheng Frederic J Kaye Lizi Wu | 2023/3/1 | |
Disparities Contributing to Late-Stage Diagnosis of Lung, Colorectal, Breast, and Cervical Cancers: Rural and Urban Poverty in Florida | Cancers | Jaclyn M Hall Rahma S Mkuu Hee Deok Cho Jennifer N Woodard Frederic J Kaye | 2023/10/31 |
A phase II randomized therapeutic optimization trial for patients with refractory metastatic colorectal cancer using circulating tumor DNA (ctDNA): Rapid 1 trial. | Sherise C Rogers Shu Wang Ryan Michael Thomas Brian Hemendra Ramnaraign Jesus C Fabregas | 2023/2/1 | |
TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background | Oncogene | Maria V Guijarro Akbar Nawab Peter Dib Sandra Burkett Xiaoping Luo | 2023/6/6 |
Co-targeting BCL-XL and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice | Cell Death Discovery | Sajid Khan Patrick Kellish Nick Connis Dinesh Thummuri Janet Wiegand | 2023/1/2 |
First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survival | JCI insight | Maria V Guijarro Patrick C Kellish Peter E Dib Nicholas G Paciaroni Akbar Nawab | 2023/5/5 |
Effects of a yoga intervention on distress indicators among diverse women with gynecologic, gastrointestinal, and thoracic cancers. | Grace Ann Hanvey Adaixa Padron Elizabeth L Kacel Kelsey C Bacharz Dennie V Jones | 2022/6/1 | |
Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival | JCI insight | Vinod Vijayakurup Kyungah Maeng Hye Seung Lee Benjamin Meyer Sandra Burkett | 2022/10/10 |
Reducing Chemotherapy-Induced DNA Damage via nAChR-Mediated Redox Reprograming—A New Mechanism for SCLC Chemoresistance Boosted by Nicotine | Cancers | Yuzhi Wang Tengfei Bian Lina Song Yunhan Jiang Zhiguang Huo | 2022/5/2 |
First in class multifunctional non classical antifolates inhibits thymidylate synthase and extends survival in pancreatic cancer model | Cancer Research | Maria V Guijarro Patrick C Kellish Peter E Dib Nicholas G Paciaroni Akbar Nawab | 2022/6/15 |
Managing stage 4 ameloblastoma with dual BRAF/MEK inhibition: A case report with 8-year clinical follow-up | Oral oncology | Zachary Abramson Orrin L Dayton Walter E Drane William M Mendenhall Frederic J Kaye | 2022/5/1 |
A BCL-XL PROTAC degrader DT2216 synergizes with KRASG12C inhibitors for effectively treating KRASG12C-mutated cancers | Cancer Research | Sajid Khan Janet Wiegand Peiyi Zhang Wanyi Hu Dinesh Thummuri | 2022/6/15 |
BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers | Journal of Hematology & Oncology | Sajid Khan Janet Wiegand Peiyi Zhang Wanyi Hu Dinesh Thummuri | 2022/3/9 |
Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre … | BMJ open | Dejana Braithwaite Shama D Karanth Christopher G Slatore Dongyu Zhang Jiang Bian | 2022/6/1 |
BCL-X | Sajid Khan Janet Wiegand Peiyi Zhang Wanyi Hu Dinesh Thummuri | 2022 |
